Quick Answer
Astaxanthin Exercise Performance Randomized Trial has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: Astaxanthin significantly reduced creatine kinase levels (SMD = -0.45, 95% CI: -0.83 to -0.07).
Key Takeaways
- 01Astaxanthin significantly reduced creatine kinase levels (SMD = -0.45, 95% CI: -0.83 to -0.07). [Liu S (2026)]
- 02Conclusions : Current evidence suggests that astaxanthin may be more beneficial for post-exercise recovery than for direct performance enhancement. [Liu S (2026)]
- 03Background : Astaxanthin is a lipid-soluble carotenoid with antioxidant and anti-inflammatory properties, but its effects on exercise performance and post-exercise recovery remain uncertain. [Liu S (2026)]
- 04This systematic review and meta-analysis aimed to evaluate the effects of astaxanthin supplementation on exercise performance and recovery-related biomarkers in healthy participants and athletes. [Liu S (2026)]
The current Migaku evidence database contains 2 reusable source documents for Astaxanthin Exercise Performance Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation.
- Astaxanthin significantly reduced creatine kinase levels (SMD = -0.45, 95% CI: -0.83 to -0.07). [Liu S (2026); evidence level 1]
- Conclusions : Current evidence suggests that astaxanthin may be more beneficial for post-exercise recovery than for direct performance enhancement. [Liu S (2026); evidence level 1]
- Background : Astaxanthin is a lipid-soluble carotenoid with antioxidant and anti-inflammatory properties, but its effects on exercise performance and post-exercise recovery remain uncertain. [Liu S (2026); evidence level 1]
- This systematic review and meta-analysis aimed to evaluate the effects of astaxanthin supplementation on exercise performance and recovery-related biomarkers in healthy participants and athletes. [Liu S (2026); evidence level 1]
- Algae supplementation showed a suggestive improvement in VO 2 max (SMD = 0.88, 95% CI: 0.00-1.75) and significantly improved in TTE (SMD = 1.06, 95% CI: 0.16-1.96), with smaller effects on WRmax (SMD = 0.29, 95% CI: 0.03-0.55), and no significant benefit for TT performance (SMD = -0.27, 95% CI: -0.74 to 0.21). [Wei Y (2026); evidence level 1]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources